CN1727471B - Application of alcohol soluble film in protein ground substance from source of plants - Google Patents
Application of alcohol soluble film in protein ground substance from source of plants Download PDFInfo
- Publication number
- CN1727471B CN1727471B CN 200510079324 CN200510079324A CN1727471B CN 1727471 B CN1727471 B CN 1727471B CN 200510079324 CN200510079324 CN 200510079324 CN 200510079324 A CN200510079324 A CN 200510079324A CN 1727471 B CN1727471 B CN 1727471B
- Authority
- CN
- China
- Prior art keywords
- plant
- film
- alcohol
- derived
- matrix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明是一种将包括小麦、大麦、裸麦、燕麦或玉米在内的植物源性醇溶蛋白基质用于细胞生长的生物医用材料和细胞因子载体。该蛋白基质系由所述的植物源性醇溶蛋白用醇溶解,并进一步在醇溶液中形成微粒子,或者将上述醇溶解液,在板上干燥后成膜。本发明的原料来源广、价格低廉、工艺要求低,提供了一种新的可降解,低免疫原性,抗菌性,具有适当机械强度生物材料。The present invention is a biomedical material and a cytokine carrier using plant-derived prolamin matrix including wheat, barley, rye, oat or corn for cell growth. The protein matrix is obtained by dissolving the plant-derived prolamin with alcohol, and further forming microparticles in the alcohol solution, or drying the above alcohol solution on a plate to form a film. The invention has wide sources of raw materials, low price and low process requirements, and provides a new degradable biological material with low immunogenicity, antibacterial properties and proper mechanical strength.
Description
本发明是名称为“植物源性醇溶蛋白基质、制备方法及用途”、申请日为2002年9月20日、申请号为02137082.6的分案申请。 The present invention is a divisional application titled "plant-derived prolamin matrix, preparation method and application", filed on September 20, 2002, and numbered 02137082.6. the
技术领域technical field
本发明涉及利用植物源成份的醇溶蛋白基质薄膜的用途。可以用作为生物材料。 The present invention relates to the use of gliadin matrix films utilizing ingredients of vegetable origin. Can be used as biological material. the
背景技术Background technique
醇溶蛋白为谷物中储存蛋白。该蛋白及其树脂具有韧性,疏水性,可降解性,抗菌性等。目前,醇溶蛋白已得到了商业化应用。在医疗上,有Coleman(2185110,2298548)生产的黏合剂,包扎工具;Cuca(WO94/121578)和Meyer et al(5609909)发明的口服药物的掩味剂;化妆品方面,有Avalle(EP 882443)创制的化装粉,食品上如Glasser(EP90559)和Wasa et al(WO 99/14076)研制的食品包装材料;科研领域,有Mathiowitz et al设计成功的微球体等。另外,玉米醇溶蛋白的应用还涉及口香糖Campbell et al(5164210)、油漆Reiners et al(3840515)、打印油墨Leckley(2570353)、胶卷Wang et al(EP 886177)、可降解性塑料(Lai et al,1997)染发剂Morawsky et al(5518717)、光纤Freeman(WO 95/01728)和纺织品(Cuq et al,1999)等诸多方面。 Glamins are storage proteins in grains. The protein and its resin have toughness, hydrophobicity, degradability, antibacterial property and so on. At present, gliadin has been commercially applied. In medicine, there are adhesives and dressing tools produced by Coleman (2185110, 2298548); taste-masking agents for oral drugs invented by Cuca (WO94/121578) and Meyer et al (5609909); in cosmetics, there is Avalle (EP 882443) Cosmetic powder created, food packaging materials such as Glasser (EP90559) and Wasa et al (WO 99/14076) developed on food; in the field of scientific research, there are microspheres successfully designed by Mathiowitz et al. In addition, the application of zein also involves chewing gum Campbell et al (5164210), paint Reiners et al (3840515), printing ink Leckley (2570353), film Wang et al (EP 886177), degradable plastics (Lai et al , 1997) hair dye Morawsky et al (5518717), fiber optic Freeman (WO 95/01728) and textiles (Cuq et al, 1999) and many other aspects. the
目前,有机合成材料已用于组织工程领域,但它们本身生物相容性不理想;或是降解速度不合适;或是降解后,其产物容易引起机体产生不良反应。如:PLGA,其酸性降解物引起了机体的炎症反应 [Hollinger et al.,1996];PLA和PGA植入人体后也有迟发性炎症反应[Bergsma et al.,1995];羟基磷灰石在生物体内很难被吸收。而一些天然生物性材料多数不能同时具有良好的各项生物学性能。目前这类材料如胶原(Nakahara et al.1989)、纤维蛋白(Kawamura et al.,1988)、明胶和甲壳素等作为生物材料,特别是在组织的修复和再生方面的应用已被广泛研究[Grzesiak et al.,1997;sofia et al.,2001;Pamela et al.,2002;Coombes et al.,2002],但它们自身多数机械强度差,往往须经修饰或同其它材料形成复合物,来增加机械强度和生物稳定性,但这同时又会引起了机体的免疫反应。如用戊二醛修饰后的胶原,在动物机体内引起了心脏瓣膜的钙化[Schoen et al.,1984]。 At present, organic synthetic materials have been used in the field of tissue engineering, but their biocompatibility is not ideal; or the degradation rate is not suitable; or after degradation, their products are likely to cause adverse reactions in the body. Such as: PLGA, its acidic degradation product caused the body's inflammatory response [Hollinger et al., 1996]; PLA and PGA also have delayed inflammatory response after implantation in the human body [Bergsma et al., 1995]; hydroxyapatite in It is difficult to be absorbed in the body. Most of some natural biological materials cannot have good biological properties at the same time. At present, such materials as collagen (Nakahara et al. 1989), fibrin (Kawamura et al., 1988), gelatin and chitin have been widely studied as biomaterials, especially in the repair and regeneration of tissues [ Grzesiak et al., 1997; sofia et al., 2001; Pamela et al., 2002; Coombes et al., 2002], but most of them have poor mechanical strength and often have to be modified or form complexes with other materials to Increases mechanical strength and biological stability, but at the same time triggers an immune response in the body. For example, collagen modified with glutaraldehyde caused calcification of heart valves in animals [Schoen et al., 1984]. the
玉米醇溶蛋白具有极好的机械强度,用120℃高温处理3小时后,经圆二相色散和电泳分析得其组成没有发生变化,证明了玉米醇溶蛋白具有良好的热稳定性,可以承受苛刻的加工工艺。此外,玉米醇溶蛋白经过修饰、加工形成可降解的薄膜,要比直接应用具有更强的韧性[Padgett et al.,1998]。 Zein has excellent mechanical strength. After being treated at 120°C for 3 hours, its composition has not changed through circular diphasic dispersion and electrophoresis analysis, which proves that zein has good thermal stability and can withstand Harsh processing technology. In addition, zein has been modified and processed to form a degradable film, which has stronger toughness than direct application [Padgett et al., 1998]. the
发明内容Contents of the invention
本发明的目的是提供一种植物源性醇溶蛋白基质,该醇溶蛋白基质主要形态为不同粒径的微粒子,也可以是由较大的粒子连成的薄膜。 The purpose of the present invention is to provide a plant-derived gliadin matrix, the main form of the gliadin matrix is microparticles with different particle sizes, and it can also be a film formed by connecting larger particles. the
本发明的目的还提供一种上述植物源性醇溶蛋白基质的制备方法。 The object of the present invention is also to provide a preparation method of the above-mentioned plant-derived gliadin matrix. the
本发明的另一目的是提供一种上述植物源性醇溶蛋白基质的用途。 Another object of the present invention is to provide a use of the above-mentioned plant-derived gliadin matrix. the
本发明是一种植物源性醇溶蛋白基质,醇溶蛋白基质主要形态是不同粒径的微粒子,也可以是由微粒子连成的薄膜。 The present invention is a plant-derived gliadin matrix. The main shape of the gliadin matrix is microparticles with different particle sizes, and it can also be a thin film formed by connecting microparticles. the
所述的微粒子为50-500nm的微粒子,所述的薄膜为50-2000nm的微粒子联成一片的薄膜。 The microparticles are 50-500nm microparticles, and the thin film is a film in which the 50-2000nm microparticles are linked together. the
所述的植物源性醇溶蛋白是小麦、大麦、裸麦、燕麦或玉米的醇溶性蛋白。 The plant-derived gliadin is the gliadin of wheat, barley, rye, oat or corn. the
所述的醇是C1-4的脂肪醇,推荐乙醇。 The alcohol is a C 1-4 fatty alcohol, ethanol is recommended.
本发明的植物源性醇溶蛋白基质制备方法,是由所述的植物源性醇溶蛋白用醇溶解,并进一步在醇溶液中形成微粒子,或者将上述醇溶解液,在板上干燥后成微粒子或膜。 The preparation method of the plant-derived prolamin matrix of the present invention is to dissolve the plant-derived prolamin with alcohol, and further form microparticles in the alcohol solution, or dry the above-mentioned alcohol solution on a plate to form microparticles or membranes. the
本发明的植物源性醇溶蛋白基质制备方法中,最好将上述的溶解植物源性醇溶蛋白的醇溶液用超声波处理,可以获得均匀大小颗粒的微粒子,或者获得由均匀大小颗粒联成一片的膜。也可以采用离心的方法,除去上述的溶解植物源性醇溶蛋白的醇溶液中较大的颗粒,使获得均匀大小颗粒的微粒子。 In the preparation method of the plant-derived prolamin matrix of the present invention, it is preferable to treat the above-mentioned alcohol solution dissolving the plant-derived prolamin with ultrasonic waves to obtain fine particles of uniform size particles, or to obtain uniform-sized particles linked into a piece membrane. Centrifugation can also be used to remove larger particles in the alcohol solution in which the plant-derived gliadin is dissolved, so as to obtain fine particles of uniform size. the
本发明的植物源性醇溶蛋白基质制备方法可以采用下述一次加醇或多次加醇的方法分别获得: The plant-derived gliadin matrix preparation method of the present invention can adopt the method for adding alcohol once or multiple times to obtain respectively:
将植物源性醇溶蛋白中加入20-60%醇的水溶液,每毫升溶液中含有0.5-100mg的植物源性醇溶蛋白,最好是每毫升溶液中含有0.5-5mg的植物源性醇溶蛋白,该溶液在板或片上,经干燥,形成微 粒子。或者将植物源性醇溶蛋白溶解在40-100%的醇溶液中,每毫升溶液中含有0.5-100mg的植物源性醇溶蛋白,再加1-100倍10-40%的醇,最好加入2-10倍10-40%的醇,形成50-500nm的微粒子。 Add 20-60% alcohol solution to the plant-derived prolamin, and each milliliter of solution contains 0.5-100 mg of plant-derived prolamin, preferably 0.5-5 mg of plant-derived prolamin per milliliter protein, the solution is dried on a plate or sheet to form microparticles. Or dissolve the plant-derived gliadin in 40-100% alcohol solution, containing 0.5-100mg of plant-derived gliadin per milliliter of solution, plus 1-100 times of 10-40% alcohol, the best Add 2-10 times of 10-40% alcohol to form 50-500nm microparticles. the
或者将植物源性醇溶蛋白溶解在50-90%的乙醇(0.5-100mg/ml)中,再加2-5倍50-90%的乙醇。超声波室温处理2-10分钟。离心2-10分钟,干燥形成微粒子联成一片的膜,是一种50-2000nm的微粒子连成一片的膜。 Alternatively, the plant-derived gliadin is dissolved in 50-90% ethanol (0.5-100 mg/ml), and 2-5 times of 50-90% ethanol is added. Ultrasonic treatment at room temperature for 2-10 minutes. Centrifuge for 2-10 minutes, and dry to form a film in which microparticles of 50-2000nm are connected in one piece. the
所述的离心机为100-800rpm。 Described centrifuge is 100-800rpm. the
所述的板可以是玻璃板、陶瓷板、不锈钢板等,也可以是生物技术所用的培养板,如24孔培养板,50-300μl/孔。 The plate can be a glass plate, a ceramic plate, a stainless steel plate, etc., or a culture plate used in biotechnology, such as a 24-well culture plate, 50-300 μl/well. the
附图说明 Description of drawings
图1、本发明的植物源性玉米醇溶蛋白的颗粒型膜基质和颗粒型膜基质扫描电镜照片。 Fig. 1, the granular membrane matrix of the plant-derived zein of the present invention and the scanning electron micrograph of the granular membrane matrix. the
图2、L-02肝细胞在本发明的不同基质上3小时的贴壁率。 Fig. 2. The adherence rate of L-02 hepatocytes on different matrices of the present invention for 3 hours. the
图3、L-02肝细胞在本发明的不同基质上活力:(A)3天,(B)6天。 Fig. 3. Viability of L-02 hepatocytes on different matrices of the present invention: (A) 3 days, (B) 6 days. the
附图1中,采用含有不同浓度的植物源性醇溶蛋白乙醇溶液形成基质后,在放大15000倍扫描电子显微镜下进行分析结果。其中1-1~1-4是颗粒型基质扫描电镜照片,1-5~1-8是颗粒型膜基质扫描电镜照片,它们的浓度分别如下:1-1:0.2%(w/v),1-2:0.4%(w/v),1-3:0.8%(w/v),1-4:1。6%(w/v),1-5:02%(w/v),1-6:0.4%(w/v),1-7:0.8%(w/v),1-8:1.6%(w/v)。 In accompanying drawing 1, after using ethanol solutions containing different concentrations of plant-derived gliadins to form a matrix, the results are analyzed under a scanning electron microscope with a magnification of 15,000 times. Wherein 1-1~1-4 are scanning electron micrographs of granular matrix, 1-5~1-8 are scanning electron microscopic pictures of granular membrane matrix, and their concentrations are as follows respectively: 1-1: 0.2% (w/v), 1-2: 0.4% (w/v), 1-3: 0.8% (w/v), 1-4: 1.6% (w/v), 1-5: 02% (w/v), 1-6: 0.4% (w/v), 1-7: 0.8% (w/v), 1-8: 1.6% (w/v). the
附图2中,表示L-02肝细胞在本发明的不同基质上的对贴壁率,其中;纵坐标-相对贴壁率,横坐标-0.康尼细胞培养板,基质准备过程中,植物源性醇溶蛋白乙醇的浓度分别为:1.200ul 0.2%(w/v);2.200ul 0.4%(w/v);3.200ul 0.8%(w/v);4.200ul 1.6%(w/v)。 In accompanying drawing 2, represent the adherence rate of L-02 hepatocyte on different substrates of the present invention, wherein; Ordinate-relative adherence rate, abscissa-0. Conny cell culture plate, in the substrate preparation process, The concentrations of plant-derived gliadin ethanol are: 1.200ul 0.2% (w/v); 2.200ul 0.4% (w/v); 3.200ul 0.8% (w/v); 4.200ul 1.6% (w/v ). the
附图3中采用含有不同浓度的植物源性醇溶蛋白乙醇溶液形成基质后,L-02肝细胞在本发明的不同基质上结果3天(3-1)和6天(3-2)后的活力。其中纵坐标-相对活性,横坐标不同浓度的植物源性醇溶蛋白乙醇溶液-1.200ul 0.2%(w/v);2.200ul 0.4%(w/v);3.200ul 0.8%(w/v);4.200ul 0.1.6%(w/v)。 In accompanying drawing 3, after adopting the ethanol solutions containing different concentrations of plant-derived gliadins to form substrates, L-02 hepatocytes produced results on different substrates of the present invention after 3 days (3-1) and 6 days (3-2) vitality. Among them, the ordinate-relative activity, the abscissa different concentrations of plant-derived gliadin ethanol solution-1.200ul 0.2% (w/v); 2.200ul 0.4% (w/v); 3.200ul 0.8% (w/v) ; 4.200ul 0.1.6% (w/v). the
附图2和3中,小颗粒表示颗粒型基质,大颗粒表示颗粒型膜基质。 In Figures 2 and 3, small particles represent granular substrates, and large particles represent granular membrane substrates. the
本发明不仅制备方法简便,而且本发明的植物源性醇溶蛋白基质是一种适合组织工程需要的可降解的高机械强度生物相容性材料。具体地说,利用体外培养技术鉴定植物源性醇溶蛋白的生物相容性,提供一种利于细胞贴附,增殖和分化的新型植物源的生物相容性的组织工程材料。该材料的原料来源广、价格低廉、工艺要求低,适合组织工程用材料。 The preparation method of the invention is simple and convenient, and the plant-derived gliadin matrix of the invention is a degradable biocompatible material with high mechanical strength suitable for tissue engineering. Specifically, the biocompatibility of plant-derived gliadin is identified by in vitro culture technology, and a new plant-derived biocompatible tissue engineering material that is beneficial to cell attachment, proliferation and differentiation is provided. The material has wide sources of raw materials, low price and low process requirements, and is suitable for tissue engineering materials. the
具体实施方式 Detailed ways
通过下述实施例将有助于理解本发明,但并不限制本发明的内容。 The following examples will help to understand the present invention, but do not limit the content of the present invention. the
实施例1: Example 1:
玉米醇溶蛋白膜制备及细胞黏附 Zein film preparation and cell adhesion
将玉米蛋白溶解80%的乙醇配制成2、4、8、16mg/ml,加4倍体积20%的乙醇,室温超声波处理5分钟,加入24孔培养板(200ul/孔供细胞培养用)或盖玻片(100ul/片 供表面分析用)300rpm离心5分钟,室温干燥,形成小颗粒型基质。 Dissolve zein in 80% ethanol to make 2, 4, 8, 16 mg/ml, add 4 times the volume of 20% ethanol, ultrasonicate at room temperature for 5 minutes, add to 24-well culture plate (200ul/well for cell culture) or The coverslips (100ul/sheet for surface analysis) were centrifuged at 300rpm for 5 minutes, and dried at room temperature to form a small particle matrix. the
70%的乙醇溶液配制玉米蛋白成2、4、8、16mg/ml,加三倍体积70%的乙醇,室温超声波处理5分钟,加入24孔培养板(200ul/孔 供细胞培养用)或盖玻片(100ul/片 供表面分析用)300rpm离心5分钟,室温干燥,形成大颗粒型基质膜 Prepare zein into 2, 4, 8, 16 mg/ml with 70% ethanol solution, add three volumes of 70% ethanol, ultrasonicate at room temperature for 5 minutes, add to 24-well culture plate (200ul/well for cell culture) or cover Slides (100ul/sheet for surface analysis) centrifuged at 300rpm for 5 minutes, dried at room temperature to form large particle matrix membrane
载有玉米醇溶蛋白膜的盖玻片置于扫描电子显微镜样品分析柱上,喷金3分钟,在4-5KeV条件下、放大15000倍进行分析(小颗粒型基质见图1-1,1-2,1-3,1-4;大颗粒型基质膜见图1-5,1-6,1-7,1-8)。 The cover glass loaded with the zein film is placed on the scanning electron microscope sample analysis column, sprayed with gold for 3 minutes, and analyzed under the condition of 4-5KeV and magnified 15000 times (see Figure 1-1, 1 for the small particle matrix. -2, 1-3, 1-4; see Fig. 1-5, 1-6, 1-7, 1-8 for the large granular matrix membrane). the
用含10%FBS,100g/ml青霉素和100mg/ml链霉素的RPMI-1640培养基,在37℃,5%CO2的培养箱中培养肝细胞。将培养至满瓶的细胞用0.25%的胰蛋白酶消化4分钟,收集细胞,活细胞染色和记数:将1滴细胞悬液与2滴台盼蓝混合,滴到记数板上,2分钟后记数。未着色的为活细胞,呈蓝色的为死细胞。用RPMI-1640调细胞密度至2.5×105个细胞/ml。1ml/孔的细胞悬液接种到含有上述玉米醇溶蛋白的24孔板中,于37℃,5%CO2的培养箱中培养。于3小时MTT法测定细胞活力,计算黏附率(结果见图2)。 Hepatocytes were cultured in RPMI-1640 medium containing 10% FBS, 100 g/ml penicillin and 100 mg/ml streptomycin in an incubator at 37 °C with 5% CO2 . Digest the cells cultured to the full bottle with 0.25% trypsin for 4 minutes, collect the cells, stain and count live cells: mix 1 drop of cell suspension with 2 drops of trypan blue, drop on the counting plate, 2 minutes Post count. Live cells are unstained and dead cells are blue. Adjust the cell density to 2.5×10 5 cells/ml with RPMI-1640. 1ml/well of the cell suspension was inoculated into a 24-well plate containing the above-mentioned zein, and cultured in an incubator at 37°C and 5% CO 2 . The cell viability was measured by the MTT method at 3 hours, and the adhesion rate was calculated (results shown in Figure 2).
实施例2 Example 2
玉米醇溶蛋白膜制备及细胞生长 Zein film preparation and cell growth
将玉米蛋白溶解80%的乙醇配制成2、4、8、16mg/ml,加4倍体积20%的乙醇,室温超声波处理5分钟,加入24孔培养板(200ul/孔供细胞培养用)或盖玻片(100ul/片 供表面分析用)300rpm离心5分钟,室温干燥,形成小颗粒型基质。 Dissolve zein in 80% ethanol to make 2, 4, 8, 16 mg/ml, add 4 times the volume of 20% ethanol, ultrasonicate at room temperature for 5 minutes, add to 24-well culture plate (200ul/well for cell culture) or The coverslips (100ul/sheet for surface analysis) were centrifuged at 300rpm for 5 minutes, and dried at room temperature to form a small particle matrix. the
70%的乙醇溶液配制玉米蛋白成2、4、8、16mg/ml,加三倍体积70%的乙醇,室温超声波处理5分钟,加入24孔培养板(200ul/孔 供细胞培养用)或盖玻片(100ul/片 供表面分析用)300rpm离心5分钟,室温干燥,形成大颗粒型基质膜。 Prepare zein into 2, 4, 8, 16 mg/ml with 70% ethanol solution, add three volumes of 70% ethanol, ultrasonicate at room temperature for 5 minutes, add to 24-well culture plate (200ul/well for cell culture) or cover Slides (100ul/sheet for surface analysis) were centrifuged at 300rpm for 5 minutes, and dried at room temperature to form a large particle matrix membrane. the
用含10%FBS,100g/ml青霉素和100mg/ml链霉素的RPMI-1640培养基,在37℃,5%CO2的培养箱中培养肝细胞。将培养至满瓶的细胞用0.25%的胰蛋白酶消化4分钟,收集细胞,活细胞染色和记数:将1滴细胞悬液与2滴台盼蓝混合,滴到记数板上,2分钟后记数。未着色的为活细胞,呈蓝色的为死细胞。用RPMI-1640调细胞密度至2.5×105个细胞/ml。1ml/孔的细胞悬液接种到含有上述玉米醇溶蛋白的24孔板中,于37℃,5%CO2的培养箱中培养。于3天、6天用MTT法测定细胞活力(结果见图3)。
Hepatocytes were cultured in RPMI-1640 medium containing 10% FBS, 100 g/ml penicillin and 100 mg/ml streptomycin in an incubator at 37 °C with 5% CO2 . Digest the cells cultured to the full bottle with 0.25% trypsin for 4 minutes, collect the cells, stain and count live cells: mix 1 drop of cell suspension with 2 drops of trypan blue, drop on the counting plate, 2 minutes Post count. Live cells are unstained and dead cells are blue. Adjust the cell density to 2.5×10 5 cells/ml with RPMI-1640. 1ml/well of the cell suspension was inoculated into a 24-well plate containing the above-mentioned zein, and cultured in an incubator at 37°C and 5% CO 2 . The cell viability was measured by MTT method on
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510079324 CN1727471B (en) | 2002-09-20 | 2002-09-20 | Application of alcohol soluble film in protein ground substance from source of plants |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510079324 CN1727471B (en) | 2002-09-20 | 2002-09-20 | Application of alcohol soluble film in protein ground substance from source of plants |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02137082 Division CN1401659B (en) | 2002-09-20 | 2002-09-20 | Preparation method of plant-derived gliadin matrix |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1727471A CN1727471A (en) | 2006-02-01 |
CN1727471B true CN1727471B (en) | 2013-03-06 |
Family
ID=35926993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510079324 Expired - Fee Related CN1727471B (en) | 2002-09-20 | 2002-09-20 | Application of alcohol soluble film in protein ground substance from source of plants |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1727471B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10228307B2 (en) | 2015-09-29 | 2019-03-12 | Biofunctions, Inc. | Dissolvable sample collection matrices and methods of using the same |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102516778A (en) * | 2011-11-29 | 2012-06-27 | 上海交通大学 | Cereal protein-based micro-carrier for large-scale culture of cells, and preparation method and application of micro-carrier |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006286A1 (en) * | 1989-11-06 | 1991-05-16 | Enzytech, Inc. | Method for producing protein microspheres |
EP0434760B1 (en) * | 1988-09-19 | 1994-01-12 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles and preparation thereof |
EP0585688A2 (en) * | 1992-08-13 | 1994-03-09 | Euro-Celtique S.A. | Aqueous dispersions of zein and controlled release coatings derived therefrom |
-
2002
- 2002-09-20 CN CN 200510079324 patent/CN1727471B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0434760B1 (en) * | 1988-09-19 | 1994-01-12 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles and preparation thereof |
WO1991006286A1 (en) * | 1989-11-06 | 1991-05-16 | Enzytech, Inc. | Method for producing protein microspheres |
EP0585688A2 (en) * | 1992-08-13 | 1994-03-09 | Euro-Celtique S.A. | Aqueous dispersions of zein and controlled release coatings derived therefrom |
Non-Patent Citations (1)
Title |
---|
T. PADGETT, et al..EFFECT OF LAURIC ACID ADDITION ON THE ANTIMICROBIAL EFFICACY AND WATER PERMEABILITY OF CORN ZEIN FILMS CONTAINING NISIN..Journal of Food Processing and Preservation.24.2001,24423-432. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10228307B2 (en) | 2015-09-29 | 2019-03-12 | Biofunctions, Inc. | Dissolvable sample collection matrices and methods of using the same |
Also Published As
Publication number | Publication date |
---|---|
CN1727471A (en) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0243818B1 (en) | Bioadhesives for cell and tissue adhesion | |
EP2365815B1 (en) | Extracellular matrix compositions for the treatment of cancer | |
Madni et al. | Fabrication and characterization of chitosan–vitamin c–lactic acid composite membrane for potential skin tissue engineering | |
Nayak et al. | Silk sericin–alginate–chitosan microcapsules: Hepatocytes encapsulation for enhanced cellular functions | |
Li et al. | Effects of concentration variation on the physical properties of alginate-based substrates and cell behavior in culture | |
JPS61108386A (en) | In vitro cell culture system | |
JPS6062979A (en) | Changing of growth of tissue culture | |
CN114080242B (en) | Method for supporting microorganisms on multiphase biological materials | |
KR20230086796A (en) | Cell culturing using nanofibers | |
Deng et al. | Heterostructured metal–organic frameworks/polydopamine coating endows polyetheretherketone implants with multimodal osteogenicity and photoswitchable disinfection | |
CN110496229B (en) | A kind of nanoparticle-coated antimicrobial peptide with sustained release and preparation method thereof | |
Zhao et al. | Polyacrylamide-sodium alginate hydrogel releasing oxygen and vitamin C promotes bone regeneration in rat skull defects | |
Nasiri et al. | Fabrication and evaluation of poly (vinyl alcohol)/gelatin fibrous scaffold containing ZnO nanoparticles for skin tissue engineering applications | |
Qu et al. | Improving bone marrow stromal cell attachment on chitosan/hydroxyapatite scaffolds by an immobilized RGD peptide | |
Tong et al. | Synthesis of the new-type vascular endothelial growth factor–silk fibroin–chitosan three-dimensional scaffolds for bone tissue engineering and in vitro evaluation | |
CN1727471B (en) | Application of alcohol soluble film in protein ground substance from source of plants | |
CN1401659B (en) | Preparation method of plant-derived gliadin matrix | |
Guan et al. | Fabrication, characterization and cell cultures on a novel chitosan scaffold | |
Nweke et al. | Fabrication and characterization of osteogenic function of progenitor cell‐laden gelatin microcarriers | |
CN112972767B (en) | A magnetic responsive tissue engineering material with promoting osteogenesis and its preparation method and application | |
CN105664244A (en) | Preparation method of porous cartilage stent | |
Bozorgi et al. | Apigenin release from chitosan/gelatin membranes promotes osteogenic differentiation of adipose-derived mesenchymal stem cells | |
Aili et al. | Evaluation of a hydroxyapatite-crosslinked fish gelatin membranes | |
US7935507B2 (en) | Method for testing substances on biomatrices | |
JPH02234670A (en) | Base material for cell culture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130306 Termination date: 20170920 |
|
CF01 | Termination of patent right due to non-payment of annual fee |